Back to Search
DAVID MENDEL, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1922397264Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Impact energy absorption of three mouthguard materials in an aqueous environment.
PMID 19208026·Dent Traumatol·2009
4-observational
Diastereoselective synthesis of a spironoraristeromycin using an acylnitroso Diels-Alder reaction.
PMID 19601571·J Org Chem·2009
8-other
Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development.
PMID 19549929·Toxicol Pathol·2009
7-preclinical
Syntheses of new spirocarbocyclic nucleoside analogs using iminonitroso Diels-Alder reactions.
PMID 19072701·Org Lett·2009
8-other
Differential scanning calorimetry (DSC) and temperature-modulated DSC study of three mouthguard materials.
PMID 17412412·Dent Mater·2007
8-other
Novel robust hepatitis C virus mouse efficacy model.
PMID 17005803·Antimicrob Agents Chemother·2006
7-preclinical
CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in mice.
PMID 16914579·Clin Cancer Res·2006
7-preclinical
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity.
PMID 16891463·Mol Cancer Ther·2006
7-preclinical
Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248.
PMID 16731761·Mol Cancer Ther·2006
4-observational
The development of potent and selective bisarylmaleimide GSK3 inhibitors.
PMID 15686883·Bioorg Med Chem Lett·2005
7-preclinical
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3.
PMID 15267232·J Med Chem·2004
7-preclinical
[Educating for quality healthcare--a conference held in Brisbane, Australia, July 2003].
PMID 14748294·Harefuah·2004
8-other
Design and synthesis of statine-containing BACE inhibitors.
PMID 14643321·Bioorg Med Chem Lett·2003
8-other
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.
PMID 14612533·Cancer Res·2003
7-preclinical
Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humans.
PMID 12966161·J Pharmacol Exp Ther·2003
7-preclinical
SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
PMID 12873999·Cancer Res·2003
7-preclinical
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.
PMID 12855656·Clin Cancer Res·2003
3-trial
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.
PMID 12748308·Mol Cancer Ther·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3000 ARLINGTON AVE
TOLEDO, OH 43614 - Phone
- (419) 383-5695
Quick Facts
- NPI
- 1922397264
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile